Larvol Delta - Cognition-Therapeutics-to-Present-Proteomic-Biomarker-Analyses-from-Clinical-Studies-of-CT1812-in-Patients-with-Alzheimers-Disease-at-ADPD-2023

Elayta (CT1812) - Cognition Therap

https://www.globenewswire.com/news-release/2023/03/21/2631235/0/en/Cognition-Therapeutics-to-Present-Proteomic-Biomarker-Analyses-from-Clinical-Studies-of-CT1812-in-Patients-with-Alzheimer-s-Disease-at-AD-PD-2023.html

Mar 21, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next